• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面分析白细胞介素 33 在肝细胞癌预后、免疫微环境和生物学功能中的作用。

Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role.

机构信息

Health Management Center, The Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.

School of Laboratory Medicine, Youjiang Medical University for Nationalities, Guangxi, China.

出版信息

J Cell Mol Med. 2024 Jun;28(12):e18468. doi: 10.1111/jcmm.18468.

DOI:10.1111/jcmm.18468
PMID:38923705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11196832/
Abstract

IL33 plays an important role in cancer. However, the role of liver cancer remains unclear. Open-accessed data was obtained from the Cancer Genome Atlas, Xena, and TISCH databases. Different algorithms and R packages are used to perform various analyses. Here, in our comprehensive study on IL33 in HCC, we observed its differential expression across cancers, implicating its role in cancer development. The single-cell analysis highlighted its primary expression in endothelial cells, unveiling correlations within the HCC microenvironment. Also, the expression level of IL33 was correlated with patients survival, emphasizing its potential prognostic value. Biological enrichment analyses revealed associations with stem cell division, angiogenesis, and inflammatory response. IL33's impact on the immune microenvironment showcased correlations with diverse immune cells. Genomic features and drug sensitivity analyses provided insights into IL33's broader implications. In a pan-cancer context, IL33 emerged as a potential tumour-inhibitor, influencing immune-related molecules. This study significantly advances our understanding of IL33 in cancer biology. IL33 exhibited differential expression across cancers, particularly in endothelial cells within the HCC microenvironment. IL33 is correlated with the survival of HCC patients, indicating potential prognostic value and highlighting its broader implications in cancer biology.

摘要

IL33 在癌症中发挥着重要作用。然而,肝癌的作用仍不清楚。本研究从癌症基因组图谱(Cancer Genome Atlas)、Xena 和 TISCH 数据库中获取了公开访问的数据。使用不同的算法和 R 包来执行各种分析。在本研究中,我们对 HCC 中的 IL33 进行了全面研究,观察到其在癌症中的差异表达,表明其在癌症发展中的作用。单细胞分析突出了其在内皮细胞中的主要表达,揭示了 HCC 微环境中的相关性。此外,IL33 的表达水平与患者的生存相关,强调了其潜在的预后价值。生物富集分析显示与干细胞分裂、血管生成和炎症反应有关。IL33 对免疫微环境的影响显示与多种免疫细胞相关。基因组特征和药物敏感性分析提供了对 IL33 更广泛影响的深入了解。在泛癌症背景下,IL33 作为一种潜在的肿瘤抑制剂,影响免疫相关分子。本研究显著提高了我们对癌症生物学中 IL33 的认识。IL33 在癌症中表现出差异表达,特别是在 HCC 微环境中的内皮细胞中。IL33 与 HCC 患者的生存相关,表明其具有潜在的预后价值,并突出了其在癌症生物学中的更广泛意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/c5fc81a81f3f/JCMM-28-e18468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/fd0885c186fa/JCMM-28-e18468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/d6dca9d92f32/JCMM-28-e18468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/e3fc2a80e7f0/JCMM-28-e18468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/9aca44923a95/JCMM-28-e18468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/a5157d8dd514/JCMM-28-e18468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/279881991550/JCMM-28-e18468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/c5fc81a81f3f/JCMM-28-e18468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/fd0885c186fa/JCMM-28-e18468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/d6dca9d92f32/JCMM-28-e18468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/e3fc2a80e7f0/JCMM-28-e18468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/9aca44923a95/JCMM-28-e18468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/a5157d8dd514/JCMM-28-e18468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/279881991550/JCMM-28-e18468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3867/11196832/c5fc81a81f3f/JCMM-28-e18468-g002.jpg

相似文献

1
Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role.全面分析白细胞介素 33 在肝细胞癌预后、免疫微环境和生物学功能中的作用。
J Cell Mol Med. 2024 Jun;28(12):e18468. doi: 10.1111/jcmm.18468.
2
Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.转移和基底膜相关特征通过整合单细胞RNA测序分析和免疫微环境评估增强肝细胞癌的预后和诊断。
J Transl Med. 2024 Jul 31;22(1):711. doi: 10.1186/s12967-024-05493-0.
3
Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis of hepatocellular carcinoma.脂质代谢基因的表达与免疫微环境相关,并可预测肝细胞癌的预后。
Sci Rep. 2024 Oct 28;14(1):25705. doi: 10.1038/s41598-024-76578-5.
4
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
5
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.基于生物信息学分析和实验验证的肝细胞癌 PANoptosis 相关亚型鉴定、预后特征构建和肿瘤微环境分析。
Front Immunol. 2024 Apr 29;15:1323199. doi: 10.3389/fimmu.2024.1323199. eCollection 2024.
6
Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.解析 ADAMs 在肝细胞癌临床异质性和免疫微环境中的作用:单细胞、空间转录组学和批量 RNA 测序的见解。
Front Immunol. 2024 Sep 13;15:1461424. doi: 10.3389/fimmu.2024.1461424. eCollection 2024.
7
Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中预后相关肿瘤微环境基因的生物信息学分析。
Med Sci Monit. 2020 Mar 31;26:e922159. doi: 10.12659/MSM.922159.
8
Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.全面泛癌基因组分析揭示 PHF19 作为一种致癌标志物与肝细胞癌的免疫浸润和预后相关。
Front Immunol. 2022 Jan 5;12:781087. doi: 10.3389/fimmu.2021.781087. eCollection 2021.
9
ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma.ncRNA 介导的 SOX4 过表达与肝细胞癌不良预后和免疫浸润相关。
BMC Gastroenterol. 2024 Aug 14;24(1):265. doi: 10.1186/s12876-024-03346-0.
10
Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression.探讨双酚 A 暴露、免疫微环境与肝细胞癌进展的相互作用。
J Gene Med. 2024 Sep;26(9):e3723. doi: 10.1002/jgm.3723.

本文引用的文献

1
IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.IL-33-ST2 信号通过 Wnt 和 Notch 通路促进髓系白血病细胞亚型的干性。
Sci Signal. 2023 Aug 29;16(800):eadd7705. doi: 10.1126/scisignal.add7705.
2
Hepatocellular Carcinoma: New Developments.肝细胞癌:新进展。
Clin Liver Dis. 2023 Feb;27(1):85-102. doi: 10.1016/j.cld.2022.08.004. Epub 2022 Oct 18.
3
Evolving therapeutic landscape of advanced hepatocellular carcinoma.晚期肝细胞癌不断演变的治疗格局。
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
4
Mechanisms and consequences of endothelial cell senescence.内皮细胞衰老的机制和后果。
Nat Rev Cardiol. 2023 Jan;20(1):38-51. doi: 10.1038/s41569-022-00739-0. Epub 2022 Jul 19.
5
IL-33 biology in cancer: An update and future perspectives.白细胞介素-33 在癌症中的生物学作用:最新研究进展和未来展望。
Cytokine. 2022 Sep;157:155961. doi: 10.1016/j.cyto.2022.155961. Epub 2022 Jul 14.
6
Autophagy and EMT in cancer and metastasis: Who controls whom?自噬与 EMT 在癌症与转移中的作用:谁在控制谁?
Biochim Biophys Acta Mol Basis Dis. 2022 Sep 1;1868(9):166431. doi: 10.1016/j.bbadis.2022.166431. Epub 2022 May 6.
7
Hepatitis B and the liver cancer endgame.乙型肝炎与肝癌的终结之战。
Nature. 2022 Mar;603(7903):S64-S65. doi: 10.1038/d41586-022-00821-0.
8
DNA repair defects in cancer and therapeutic opportunities.癌症中的 DNA 修复缺陷与治疗机会。
Genes Dev. 2022 Mar 1;36(5-6):278-293. doi: 10.1101/gad.349431.122.
9
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.真菌微生物组驱动胰腺癌中的 IL-33 分泌和 2 型免疫。
Cancer Cell. 2022 Feb 14;40(2):153-167.e11. doi: 10.1016/j.ccell.2022.01.003. Epub 2022 Feb 3.
10
Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function.阻断 IL-33-ST2-AKT 信号轴通过抑制小胶质细胞代谢适应和吞噬功能损害神经发育。
Immunity. 2022 Jan 11;55(1):159-173.e9. doi: 10.1016/j.immuni.2021.12.001. Epub 2022 Jan 3.